Biomarker analysis in Phase 1b study of anti-cancer stem cell antibody Tarextumab (TAR) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) demonstrates pharmacodynamic (PD) modulation of the Notch pathway in patients (pts) with untreated metastatic pancreatic cancer (mPC) Meeting Abstract
| Authors: | Kapoun, A.; O'reilly, E.; Cohn, A.; Bendell, J. C.; Smith, L.; Strickler, J. H.; Gluck, W.; Liu, Y. W.; Wallace, B.; Tam, R.; Cancilla, B.; Brunner, A.; Hill, D.; Zhou, L.; Dupont, J.; Zhang, C.; Wang, M. |
| Abstract Title: | Biomarker analysis in Phase 1b study of anti-cancer stem cell antibody Tarextumab (TAR) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) demonstrates pharmacodynamic (PD) modulation of the Notch pathway in patients (pts) with untreated metastatic pancreatic cancer (mPC) |
| Meeting Title: | 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 50 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2014 Nov 18-21 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2014-11-01 |
| Start Page: | 152 |
| Language: | English |
| ACCESSION: | WOS:000347755700466 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(14)70591-X |
| Notes: | Meeting Abstract: 465 -- 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 18-21, 2014 -- Barcelona, SPAIN -- Source: Wos |
